Pfizer PFE reported positive top-line results from a late-stage study evaluating Talzenna (talazoparib), an oral PARP inhibitor, in combination with Xtandi (enzalutamide), an ARP inhibitor. The ...

A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...

This week, cancer researchers in New York are one step closer to answering a question that has plagued medical and environmental advocates for decades: What is the role of plastic exposure in the ...

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come ...

Longtime friends and allies of Joe Biden say they are worried about the toll an aggressive form of prostate cancer is taking on the former president and his health. But Biden and his aides say he is ...

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

Prostatic artery embolization (PAE) has become established as a minimally invasive treatment option for benign prostatic hyperplasia (BPH) in recent years. This review aims to provide a coherent ...